Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.08300.0000 (0.00%)
At close: 05:04PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 22.03M
Enterprise value 22.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)9.51
Price/book (mrq)9.45
Enterprise value/revenue 9.65
Enterprise value/EBITDA -4.87

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-70.36%
S&P500 52-week change 3-8.83%
52-week high 30.2800
52-week low 30.0700
50-day moving average 30.0932
200-day moving average 30.1505

Share statistics

Avg vol (3-month) 3156.95k
Avg vol (10-day) 335.37k
Shares outstanding 5265.45M
Implied shares outstanding 6N/A
Float 8142.59M
% held by insiders 148.84%
% held by institutions 13.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -256.92%
Operating margin (ttm)-249.82%

Management effectiveness

Return on assets (ttm)-24.10%
Return on equity (ttm)-112.86%

Income statement

Revenue (ttm)2.33M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-17.80%
Gross profit (ttm)498.12k
EBITDA -4.94M
Net income avi to common (ttm)-5.98M
Diluted EPS (ttm)-0.0230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.96M
Total cash per share (mrq)0.01
Total debt (mrq)4.25M
Total debt/equity (mrq)182.18
Current ratio (mrq)2.53
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-4.62M
Levered free cash flow (ttm)-2.86M